Neural and vascular cellular adhesion molecules are associated with cognitive function in patients with schizophrenia-spectrum disorders: A longitudinal study
Schizophrenia Research · 2026
DOI: 10.1016/j.schres.2026.01.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Schizophrenia Research, 2026. Verfasst von Kristian Varden Gjerde und 12 weiteren Autor:innen. Beteiligte Einrichtung: NKS Olaviken Gerontopsychiatric Hospital, Erdal, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway; Division of Psychiatr…. Hauptthemen laut MEDLINE: Schizophrenia, Cell Adhesion Molecules, Cognitive Dysfunction, Psychotic Disorders. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Western Norway Regional Health Authority, Research Council of Norway, EEA Grants and Norway Grants.
Abstract (Originalsprache)
BACKGROUND: Schizophrenia patho-etiology may involve endothelial inflammation and blood-brain barrier (BBB) dysregulation with cellular adhesion molecules (CAMs) as important mediators. CAMs are essential for cellular integrity but can show increased levels in inflammation. Cognitive dysfunction precedes and exists independently of psychotic symptoms in schizophrenia patients. CAMs could impact cognition through influence on BBB integrity. To gain insights into disease mechanisms and potential therapeutic targets, we explored the relationship between CAMs protein levels and neurocognitive tests in schizophrenia-spectrum disorders in the BeSt InTro study. METHODS: Seventy-one in- and out-patients underwent CAMs measurements and neuropsychological testing on a minimum of one time point: baseline, 6, 26, or 52 weeks. Cognitive domains included working memory, processing speed, verbal abilities, executive functions, and overall cognition. CAMs analyzed were neural CAMs: junctional adhesion molecule (JAM-A) and neural cadherin (N-CAD); vascular CAMs: intercellular adhesion molecule (ICAM)-1, vascular adhesion molecule (VCAM)-1, mucosal addressin cell adhesion molecule (MADCAM), and platelet (P)-selectin from fasting blood samples. Linear mixed effects models, adjusted for age, sex, body mass index, smoking, education, and drug naivety, estimated CAMs effect on cognitive outcome measures. RESULTS: N-CAD levels correlated positively with overall cognition (p = 0.002), working memory (p = 0.034), and executive functions (p = 0.0011). ICAM-1 levels correlated positively with overall cognition (p = 0.037). Conversely, JAM-A levels correlated negatively with executive functions (p = 0.021). CONCLUSION: Associations between CAMs (N-CAD, ICAM-1, JAM-A) and neurocognitive tests suggest CAMs may impact cognition in schizophrenia. Contrary to our hypothesis, most associations between CAMs levels and cognitive tests were positive. Future research on mechanisms is mandatory.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NKS Olaviken Gerontopsychiatric Hospital, Erdal, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway; Division of Psychiatry, Haukeland University Hospital, Bergen, Norway; Mohn Research Center…
- Division of Psychiatry, Haukeland University Hospital, Bergen, Norway; Mohn Research Center for Psychotic Disorders, Bergen, Norway.
- Division of Psychiatry, Haukeland University Hospital, Bergen, Norway; Mohn Research Center for Psychotic Disorders, Bergen, Norway; Department of Clinical Psychology, University of Bergen, Bergen, Norway.
- Mohn Research Center for Psychotic Disorders, Bergen, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway; Dr. Einar Martens Research Group for Biological Psychiatry, Department of Medical Genet…
- Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University…
- Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Research Institute of Internal Medicine, Oslo Unive…
Förderung
- Western Norway Regional Health Authority
- Research Council of Norway
- EEA Grants and Norway Grants
Zitieren
APA
Varden Gjerde, K., Bartz-Johannessen, C., Løberg, E. M., Steen, V. M., Steen, N. E., Andreassen, O. A., Ueland, T., Rettenbacher, M., Joa, I., Reitan, S. K., Fathian, F., Johnsen, E., & Kroken, R. A. (2026). Neural and vascular cellular adhesion molecules are associated with cognitive function in patients with schizophrenia-spectrum disorders: A longitudinal study. Schizophrenia Research. https://doi.org/10.1016/j.schres.2026.01.021
Vancouver
Varden Gjerde K, Bartz-Johannessen C, Løberg EM, Steen VM, Steen NE, Andreassen OA, et al. Neural and vascular cellular adhesion molecules are associated with cognitive function in patients with schizophrenia-spectrum disorders: A longitudinal study. Schizophrenia Research. 2026. doi:10.1016/j.schres.2026.01.021
BibTeX
@article{VardenGjerde2026,
author = {Varden Gjerde, Kristian and Bartz-Johannessen, Christoffer and Løberg, Else-Marie and Steen, Vidar Martin and Steen, Nils Eiel and Andreassen, Ole A and Ueland, Thor and Rettenbacher, Maria and Joa, Inge and Reitan, Solveig Klæbo and Fathian, Farivar and Johnsen, Erik and Kroken, Rune Andreas},
title = {Neural and vascular cellular adhesion molecules are associated with cognitive function in patients with schizophrenia-spectrum disorders: A longitudinal study},
journal = {Schizophrenia Research},
year = {2026},
doi = {10.1016/j.schres.2026.01.021}
}
EUVIMED